Localized prostate cancer disparities in risk group at presentation and access to treatment for Hispanic men

Shorter Radiation Regimens and Treatment Noncompletion Among Patients With Breast and Prostate Cancer in the United States: An Analysis of Racial Disparities in Access and Quality

“…These structural barriers are broad, ranging from disproportionately lower socioeconomic status and high rates of uninsurance owing to historical and present injustices inflicted on minoritized groups and subsequent mistrust of the medical system. 26,27,36 Although it could be argued that part of the disparity in access to shorter radiation courses could be attributed to greater risk of presenting with more advanced disease among minoritized groups, 25,37,38 such an explanation further reflects inequities that persist at each point in the cancer spectrum, ranging from suboptimal screening to delays in treatment initiation. [23][24][25]27,37,38 Indeed, Black communities shoulder the highest cancer mortality burden from BC and PC in the United States, with recent survival estimates 8%-20% lower than other groups.…”

“…26,27,36 Although it could be argued that part of the disparity in access to shorter radiation courses could be attributed to greater risk of presenting with more advanced disease among minoritized groups, 25,37,38 such an explanation further reflects inequities that persist at each point in the cancer spectrum, ranging from suboptimal screening to delays in treatment initiation. [23][24][25]27,37,38 Indeed, Black communities shoulder the highest cancer mortality burden from BC and PC in the United States, with recent survival estimates 8%-20% lower than other groups. 39 Although factors driving these disparities are multifactorial, radiation treatment noncompletion has been shown to negatively affect treatment efficacy across cancer types.…”

“…[17][18][19][20][21] Despite these advances in radiotherapy techniques, inequities in their utilization and subsequent disparities in oncologic outcomes persist for Black versus non-Black patients with BC and PC in the United States. [22][23][24][25][26] This is attributable in part to systemic bias and barriers in access to care. 27 One important potential benefit of shorter fractionation schemes is an improvement in treatment completion rates among patients receiving radiation therapy (RT).…”

Non‐small cell lung cancer disparities in stage at presentation and treatment for Asian American, Native Hawaiian, and Pacific Islander women

“…Lastly, causal mechanisms of the observed heterogeneity in stage at presentation also require further exploration. Prior disaggregation studies suggest social determinants of health, such as insurance status, socioeconomic status, and education could play a mediating role, 35 but these findings remain unexplored in AANHPI populations.…”

In pursuit of equity in cancer care: Moving beyond the Affordable Care Act

“…It is important to note that although the work of Snyder et al 33 does not explicitly examine cancer outcomes (indeed, the National Cancer Database reports only overall survival and not cancer-specific outcomes), disparities in stage at presentation may only represent the "tip of the iceberg"; disparities in treatment and the survivorship setting after diagnosis lead to more disparate cancer outcomes. [40][41][42][43][44][45] The persistence of cancer disparities despite interventions aimed at improving access to care highlight that despite Cancer September 15, 2022 improvements in insurance coverage, there are other factors at play that mediate cancer disparities.…”